학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 144건 | 목록 1~10
Editorial & Opinion
Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Silvestri M; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; De Marco C; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Reduzzi C; Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.; Folli S; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; De Santis MC; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publisher: SAGE Publishing Country of Publication: United States NLM ID: 8712411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6008 (Electronic) Linking ISSN: 03936155 NLM ISO Abbreviation: Int J Biol Markers Subsets: MEDLINE
Academic Journal
Nader-Marta G; Academic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: guilherme.nader.marta@ulb.be.; Monteforte M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.; Agostinetto E; Academic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: https://twitter.com/ElisaAgostinett.; Cinquini M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.; Martins-Branco D; Academic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: https://twitter.com/DMBranco.; Langouo M; Medical Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (U.L.B), Brussels, Belgium.; Llombart-Cusac A; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Medica Scientia Innovation Research (MEDSIR), Ridgewood, New Jersey, USA; Arnau de Vilanova Hospital; Universidad Católica de Valencia, Valencia, Spain.; Cortés J; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Medica Scientia Innovation Research (MEDSIR), Ridgewood, New Jersey, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain. Electronic address: https://twitter.com/JavierCortesMD.; Ignatiadis M; Academic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: https://twitter.com/MIgnatiadis.; Torri V; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Electronic address: https://twitter.com/ValterTorri.; Apolone G; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Pruneri G; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. Electronic address: https://twitter.com/PruneriG.; de Azambuja E; Academic Trials Promoting Team (ATPT), Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: https://twitter.com/E_de_Azambuja.; Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: https://twitter.com/serenadicosimo.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Pizzamiglio S; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. sara.pizzamiglio@istitutotumori.mi.it.; Ciniselli CM; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Duroni V; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; De Cecco L; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; De Marco C; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Silvestri M; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; De Santis MC; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Vingiani A; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Paolini B; Department of Pathology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Orlandi R; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Iorio MV; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Pruneri G; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Verderio P; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Sepe P; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Giacomo Venezian 1, Milan 20133, Italy.; Procopio G; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Programma Prostata, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Pircher CC; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Basso U; Oncology Unit 1, Department of Medical Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.; Caffo O; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy.; Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.; Claps M; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.; Fratino L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, IRCCS, Aviano, Italy.; Guadalupi V; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Miodini P; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.; De Marco C; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.; Perrucci B; Oncology Department, ASST Istituti Ospitalieri, Cremona, Italy.; Mennitto A; Department of Medical Oncology, University Hospital Maggiore della Carità, Novara, Italy.; Medical Oncology, Department of Translational Medicine (DIMET), University of Eastern Piedmont (UPO), Novara, Italy.; Santini D; Oncologia Medica, Campus Bio-Medico University of Rome, Rome, Italy.; University of Rome La Sapienza, Roma, Italy.; Spina F; Department of Hematology and Oncology, Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy.; Stellato M; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; de Braud F; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Verzoni E; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Academic Journal
Reduzzi C; Biomarkers Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Division of Hematology/Oncology, Weill Cornell Medicine, New York, United States.; Vismara M; Biomarkers Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Schamberger T; Experimental Medicine and Therapy Research, University Regensburg, Regensburg, Germany.; Silvestri M; Biomarkers Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Motta R; Biomarkers Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Polzer BM; Cellular and Molecular Diagnostics Group, Division of Personalized Cancer Therapy, Fraunhofer Institute of Toxicology and Experimental Medicine ITEM-R, Regensburg, Germany.; Cappelletti V; Biomarkers Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Milan, Italy. Vera.Cappelletti@istitutotumori.mi.it.
Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE
Academic Journal
Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. Electronic address: rosalba.miceli@istitutotumori.mi.it.; Ljevar S; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.; Trama A; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Bernasconi A; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Lasalvia P; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; De Santis MC; Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.; Miceli R; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.; Apolone G; Scientific Directorate, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Academic Journal
Chiodoni C; Fondazione IRCCS Istituto Nazionale dei Tumori, Experimental Oncology Department, Molecular Immunology Unit, Milan.; Sangaletti S; Fondazione IRCCS Istituto Nazionale dei Tumori, Experimental Oncology Department, Molecular Immunology Unit, Milan.; Lecchi M; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Epidemiology and Data Science, Unit of Bioinformatics and Biostatistics, Milan.; Ciniselli CM; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Epidemiology and Data Science, Unit of Bioinformatics and Biostatistics, Milan.; Cancila V; University of Palermo School of Medicine, Department of Health Sciences, Tumor Immunology Unit, Palermo.; Tripodi I; Fondazione IRCCS Istituto Nazionale dei Tumori, Experimental Oncology Department, Molecular Immunology Unit, Milan.; Ratti C; Fondazione IRCCS Istituto Nazionale dei Tumori, Experimental Oncology Department, Molecular Immunology Unit, Milan.; Talarico G; Fondazione IRCCS Istituto Nazionale dei Tumori, Experimental Oncology Department, Molecular Immunology Unit, Milan.; Brich S; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Pathology, Milan.; De Cecco L; Fondazione IRCCS Istituto Nazionale dei Tumori, Experimental Oncology Department, Molecular Mechanisms Unit, Milan.; Baili P; Fondazione IRCCS Istituto Nazionale dei Tumori, Analytical Epidemiology and Health Impact Unit, Milan.; Truffi M; Istituti Clinici Scientifici Maugeri IRCCS, Laboratory of Nanomedicine, Pavia.; Sottotetti F; Istituti Clinici Scientifici Maugeri IRCCS, Medical Oncology Unit, Pavia.; Piccotti F; Istituti Clinici Scientifici Maugeri IRCCS, Laboratory of Nanomedicine, Pavia.; Tripodo C; University of Palermo School of Medicine, Department of Health Sciences, Tumor Immunology Unit, Palermo; FIRC Institute of Molecular Oncology (IFOM), Milan.; Pruneri G; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Pathology, Milan.; Triulzi T; Fondazione IRCCS Istituto Nazionale dei Tumori, Experimental Oncology Department, Molecular Targeting Unit, Milan.; Corsi F; Istituti Clinici Scientifici Maugeri IRCCS, Surgery Department, Breast Unit, Pavia; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milan.; Cappelletti V; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Advanced Diagnostics, Biomarkers Unit, Milan, Italy.; Di Cosimo S; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Advanced Diagnostics, Biomarkers Unit, Milan, Italy.; Verderio P; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Epidemiology and Data Science, Unit of Bioinformatics and Biostatistics, Milan.; Colombo MP; Fondazione IRCCS Istituto Nazionale dei Tumori, Experimental Oncology Department, Molecular Immunology Unit, Milan. Electronic address: mariopaolo.colombo@istitutotumori.mi.it.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Malinovska L; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Cappelletti V; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Kohler D; Khoury College of Computer Sciences, Northeastern University, Boston, MA, USA.; Piazza I; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC Berlin), Berlin, Germany.; Tsai TH; Department of Mathematical Sciences, Kent State University, Kent, OH, USA.; Pepelnjak M; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Stalder P; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Dörig C; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Sesterhenn F; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Elsässer F; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Kralickova L; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Beaton N; Biognosys AG, Schlieren, Switzerland.; Reiter L; Biognosys AG, Schlieren, Switzerland.; de Souza N; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Vitek O; Khoury College of Computer Sciences, Northeastern University, Boston, MA, USA. o.vitek@northeastern.edu.; Picotti P; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland. picotti@imsb.biol.ethz.ch.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101284307 Publication Model: Print Cited Medium: Internet ISSN: 1750-2799 (Electronic) Linking ISSN: 17502799 NLM ISO Abbreviation: Nat Protoc Subsets: PubMed not MEDLINE; MEDLINE
Editorial & Opinion
Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy. Electronic address: serena.dicosimo@istitutotumori.mi.it.; Apolone G; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.; Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.; Torri V; Laboratory of Methodology for Biomedical Research, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Silvestri M; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Unit of Biostatistics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; Nghia Vu T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Nichetti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Di Cosimo S; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; De Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Pruneri G; Department Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Pawitan Y; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Calza S; Unit of Biostatistics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; Cappelletti V; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Cappelletti V
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어